Physician

Hematology

Dr. Belinda R. Avalos, MD

Belinda Avalos is an expert in the field of Hematology. Belinda R. Avalos is a published doctor and has 69 publications published. The lastest was: 'Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia.'

Publications

Bring on the Biosimilars!
Comparison of Outcomes of Allogeneic Transplantation for CML with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan or TBI.
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared to TBI.
An Update on Stem Cell Transplantation in Autoimmune Rheumatologic Disorders.
Can G-CSF cause leukemia in hematopoietic stem-cell donors?
Late mortality and relapse following BuCy2 and HLA-identical sibling marrow transplantation for chronic myelogenous leukemia.
Role of the proteasome in modulating native G-CSFR expression.
LRG-accelerated differentiation defines unique G-CSFR signaling pathways downstream of PU.1 and C/EBPepsilon that modulate neutrophil activation.
Divergent pathways in COS-7 cells mediate defective internalization and intracellular routing of truncated G-CSFR forms in SCN/AML.
G-CSFR ubiquitination critically regulates myeloid cell survival and proliferation.
High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation.
Syngeneic vs. allotransplantation in chronic myeloid leukemia: all's well that ends well.
Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating pro...
Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia.
Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acut...
Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression o...
Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation.
Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines.
K562 cells produce and respond to human erythroid-potentiating activity.
Nonhematopoietic tumor cells express functional GM-CSF receptors.
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation.
Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia.
The c-kit ligand potentiates the allogeneic mixed lymphocyte reaction.
Psoralen plus ultraviolet A (PUVA) in the treatment of chronic graft versus host disease: preliminary experience in standard treatment resistant patients.
Diffuse alveolar hemorrhage following gemtuzumab ozogamicin.
The granulocyte colony-stimulating factor receptor and its role in disorders of granulopoiesis.
Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin''s lymphoma.
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical...
Effect of GVHD on the recovery of NK cell activity and LAK precursors following BMT.
Controlled trial of orally administered immunoglobulin following bone marrow transplantation.
Molecular analysis of the granulocyte colony-stimulating factor receptor.
Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications followi...
Influence of graft-versus-host disease on outcome following allogeneic transplantation with radiation-free preparative therapy in patients with advanced leukemia.
Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged >or=50 years compared to younger adults...
Second autologous stem cell transplant for multiply relapsed Hodgkin''s disease.
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid l...
The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy.
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.
Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformat...
Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an update.
Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation ...
Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines.
Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia.
Second autologous bone marrow transplantation in Hodgkin''s disease.
HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation.
Alternate applications of immunoglobulin following bone marrow transplantation.
The active monomeric form of macrophage inflammatory protein-1 alpha interacts with high- and low-affinity classes of receptors on human hematopoietic cells.
Dissociation of the Jak kinase pathway from G-CSF receptor signaling in neutrophils.
Allogeneic bone marrow transplantation for leukemia using chemotherapy as conditioning: 6-year results of a single institution trial.
Abnormal response to granulocyte colony-stimulating factor (G-CSF) in canine cyclic hematopoiesis is not caused by altered G-CSF receptor expression.
Allogeneic bone marrow transplantation following busulfan and 90 mg/kg of cyclophosphamide.
Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2.
Radiation-free preparation for allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide.
Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
Preparation for marrow transplantation in Hodgkin''s and non-Hodgkin''s lymphoma using Bu/CY.
Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cycloph...
Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymp...
Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and...
Phosphatidylinositol 3'-kinase and SH2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granuloc...
Point mutations in the conserved box 1 region inactivate the human granulocyte colony-stimulating factor receptor for growth signal transduction and tyrosine phosphory...
Cyclosporine-associated seizures in bone marrow transplant recipients given busulfan and cyclophosphamide preparative therapy.
Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2.
Neutrophil elastase downmodulates native G-CSFR expression and granulocyte-macrophage colony formation.
Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia.
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma.

Schools

Ohio State University College of Medicine

Doctors Specialties

Hematology

Accepted Insurances

Education

UCLA Medical Center
Ohio State University Hospital

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Nilanjan Ghosh, MD This Doctor is OpenDoctor Recommended.
	Dr. Edward A. Copelan, MD This Doctor is OpenDoctor Recommended.
	Dr. Kwabena Osei-Boateng, MD
	Dr. Manisha Bhutani, MD This Doctor is OpenDoctor Recommended.